Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Palestine · Delayed Price · Currency is JOD · Price in USD

3.680

0.00 (0.00%)

At close: Jun 17, 2026

91.17% (1Y)

Market Cap	93.90M +90.8%
Revenue (ttm)	35.57M +22.9%
Net Income	7.24M +102.1%
EPS	0.20 +102.1%
Shares Out	36.00M
PE Ratio	12.96
Forward PE	n/a
Dividend	0.05 (2.06%)
Ex-Dividend Date	Apr 16, 2026

Volume	574
Open	3.680
Previous Close	n/a
Day's Range	3.680 - 3.680
52-Week Range	1.900 - 4.000
Beta	0.43
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 6, 2026

About Jerusalem Pharmaceuticals

Jerusalem Pharmaceuticals Co. Ltd., together with its subsidiaries, develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally. The company offers over the counter, prescription pharmaceutical, and nutritional supplements products in various dosage forms, including tablets, capsules, sterile injectables, powders for suspensions, suspensions, syrups, powders, suppositories, ovules, creams, and ointments, as well as ear and nose drops and solutions. It also provides medical devices... [Read more]

Industry Pharmaceutical Preparations

Founded 1969

Employees 595

Stock Exchange Palestine Stock Exchange

Ticker Symbol JPH

Full Company Profile

Financial Performance

In 2025, Jerusalem Pharmaceuticals's revenue was $48.95 million, an increase of 22.91% compared to the previous year's $39.82 million. Earnings were $10.18 million, an increase of 102.13%.

Financial numbers in USD Financial Statements